<table id="table9" width="75%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 9. Bioavailability of Divalproex Sodium Extended-Release Tablets Relative to Divalproex Sodium Delayed-Release Tablets When Divalproex Sodium Extended-Release Tablets Dose is 8 to 20% Higher</caption>
<col align="left" valign="top" width="35%"></col>
<col align="left" valign="top" width="35%"></col>
<col align="center" valign="top" width="10%"></col>
<col align="center" valign="top" width="10%"></col>
<col align="center" valign="top" width="10%"></col>
<thead>
<tr stylecode="Botrule">
<th stylecode="Lrule Rrule">Study Population</th>
<th stylecode="Rrule">Regimens</th>
<th align="center" colspan="3" stylecode="Rrule">Relative Bioavailability</th>
</tr>
<tr>
<th stylecode="Lrule Rrule"></th>
<th stylecode="Rrule">Divalproex Sodium Extended-Release Tablets vs. Divalproex Sodium Delayed-Release Tablets</th>
<th stylecode="Rrule">AUC<sub>24</sub>
</th>
<th stylecode="Rrule">C<sub>max</sub>
</th>
<th stylecode="Rrule">C<sub>min</sub>
</th>
</tr>
</thead>
<tbody>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Healthy Volunteers (N=35)</td>
<td stylecode="Rrule">1000 &amp; 1500 mg Divalproex Sodium Extended-Release Tablets vs. 875 &amp; 1250 mg Divalproex Sodium Delayed-Release Tablets</td>
<td stylecode="Rrule">1.059</td>
<td stylecode="Rrule">0.882</td>
<td stylecode="Rrule">1.173</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">Patients with epilepsy on concomitant enzyme-inducing antiepilepsy drugs (N=64)</td>
<td stylecode="Rrule">1000 to 5000 mg Divalproex Sodium Extended-Release Tablets vs. 875 to 4250 mg Divalproex Sodium Delayed-Release Tablets</td>
<td stylecode="Rrule">1.008</td>
<td stylecode="Rrule">0.899</td>
<td stylecode="Rrule">1.022</td>
</tr>
</tbody>
</table>